US Stock MarketDetailed Quotes
DWTX Dogwood Therapeutics
- 4.430
- +0.770+21.04%
Close Oct 16 16:00 ET
5.90MMarket Cap-770P/E (TTM)
4.900High3.500Low207.71KVolume3.640Open3.660Pre Close873.29KTurnover16.52%Turnover RatioLossP/E (Static)1.33MShares26.00052wk High1.88P/B5.57MFloat Cap2.50152wk Low--Dividend TTM1.26MShs Float417.750Historical High--Div YieldTTM38.25%Amplitude2.501Historical Low4.204Avg Price1Lot Size
About Dogwood Therapeutics Company
Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.
Company Profile
SymbolDWTX
Company NameDogwood Therapeutics
Listing DateDec 17, 2020
Founded2012
CEOMr. Gregory Duncan
MarketNASDAQ
Employees4
Fiscal Year Ends12-31
Address44 Milton Avenue
CityAlpharetta
ProvinceGeorgia
CountryUnited States of America
Zip Code30009
Phone1-866-620-8655
Websitehttp://www.dwtx.com
Company Executives
- Name
- Position
- Salary
- Gregory Duncan
- Chief Executive Officer and Chairman of the Board
- 936.83K
- Dr. Roger Michael Gendreau, M.D.,PhD
- Chief Medical Officer
- 566.18K
- Angela Walsh
- Chief Financial Officer, Corporate Secretary and Treasurer
- 426.82K
- Ralph Grosswald
- Senior Vice President, Operations
- --
- Ying Choi Alan Abel Yu
- Director
- --
- Dr. Melvin Toh, PhD
- Director
- --
- John C. Thomas,Jr
- Independent Director
- 66.49K
- Dr. William L. Pridgen, M.D.
- Independent Director
- 51.49K
- Dr. Richard J. Whitley,M.D.
- Independent Director
- 64.49K
- David Keefer
- Independent Director
- 72.99K
- Dr. Abel De La Rosa,PhD
- Independent Director
- 63.99K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data